Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases
NCT ID: NCT00629954
Last Updated: 2013-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2009-11-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information.
Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients have to agree to participate by signing a consent
* 18 years and older
Exclusion Criteria
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Ministry of Health, Nigeria
OTHER_GOV
Akaza Research
INDUSTRY
Byrne Healthcare
INDUSTRY
Baim Institute for Clinical Research
OTHER
Healthsystem Plus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
uchenna onyeachom
Study Director/ Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uchenna N Onyeachom
Role: PRINCIPAL_INVESTIGATOR
Healthsystem Plus
Ngozi A Njepuome
Role: PRINCIPAL_INVESTIGATOR
Abuja Heart Study
Chimele Abengowe
Role: STUDY_CHAIR
National Hospital, Abuja
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Hospital Abuja
Abuja, Federal Capital Territory, Nigeria
State House Medical Center
Abuja, Federal Capital Territory, Nigeria
Bwari General Hospital
Bwari, Federal Capital Territory, Nigeria
Nigerian Defense Medical Center
Abuja, , Nigeria
Gwagwalada Specialist Hospital
Federal Capital Territory, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIFA-001
Identifier Type: -
Identifier Source: org_study_id